What does Imed Infinity Medical-Limited Partnership do?

Imed Infinity Medical-Limited Partnership (IMED.TA) operates in the Medical - Healthcare Information Services industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is IMED.TA's market cap?

Imed Infinity Medical-Limited Partnership (IMED.TA) has a market capitalization of approximately $604.7 million, as of August 18, 2026, based on the most recent share price and shares outstanding.

Does IMED.TA pay a dividend?

No — Imed Infinity Medical-Limited Partnership (IMED.TA) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Is IMED.TA profitable?

Imed Infinity Medical-Limited Partnership (IMED.TA) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

IMED.TA

Imed Infinity Medical-Limited Partnership

TLV·Medical, Healthcare Information Services · Healthcare

ILA 88.60ILA 0.00+0.00%

Market capILA 604.70M·Aug 18 1:16 PM UTC

Price Chart

ILA 88.60+ILA 0.00 (+0.00%)today

−78.90%CAGR −26.75%

Select date range

FromTo

Dec 29, 2020Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

IMED.TA does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

Revenue$657.00K

Net Income−$80.26K

Net Margin−12.2%

Operating Cash Flow−$368.04K

Capital Expenditures$0.00

Free Cash Flow−$368.04K

Return on Equity−1.3%

Return on Invested Capital−9.1%

Net Cash$2.88M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for IMED.TA and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how IMED.TA's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for IMED.TA and 80,000+ other tickers.

About Imed Infinity Medical-Limited Partnership

Operating as a research and development partnership, Imed Infinity Medical-Limited Partnership was founded in 2020 and is located in Tel Aviv, Israel. Its central mission involves providing capital for R&D ventures within the medical domain, especially those focused on digital health.

CEO: Itay Gal-Or
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Exchange: TLV
Employees: 70
Website: www.infinitymedical.co.il

Peers

Latest News

News Tab

No recent news available.

Frequently Asked Questions About IMED.TA

What does Imed Infinity Medical-Limited Partnership do?: Imed Infinity Medical-Limited Partnership (IMED.TA) operates in the Medical - Healthcare Information Services industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is IMED.TA's market cap?: Imed Infinity Medical-Limited Partnership (IMED.TA) has a market capitalization of approximately $604.7 million, as of August 18, 2026, based on the most recent share price and shares outstanding.
Does IMED.TA pay a dividend?: No — Imed Infinity Medical-Limited Partnership (IMED.TA) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is IMED.TA profitable?: Imed Infinity Medical-Limited Partnership (IMED.TA) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.